Physician profile

Brandon Tullis

Podiatrist · Modesto, CA

NPI 1568410348

$2,790.09

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$324.23
Travel and Lodging$170.57

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sequoia Surgical, INC. $1,266.61 2019
Stryker Corporation $934.26 2019
Paragon 28, INC. $445.72 2023-2024 Apex 3d, Grappler
Arthrosurface Incorporated $58.85 2020
Smith+Nephew, INC. $35.57 2019-2020
Orthofix Medical, INC. $29.72 2023 Physio-Stim
Cornerstone Medical Associates, INC. $19.36 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Brandon Tullis

$2,790.09

in general payments reported 2019-2025

Years
2019-2024
Top company
Sequoia Surgical, INC.

https://glasscript.com/doctor/26024/brandon-tullis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.